| Literature DB >> 27421466 |
Ravinder Mamtani1, Sohaila Cheema2, Javaid Sheikh3, Ahmad Al Mulla4, Albert Lowenfels5, Patrick Maisonneuve6.
Abstract
OBJECTIVES: To quantify by meta-analysis the relationship between waterpipe smoking and cancer, including cancer of the head and neck, esophagus, stomach, lung and bladder.Entities:
Keywords: Cancer; Hubble bubble; Meta-analysis; Shisha; Smoking; Waterpipe
Mesh:
Substances:
Year: 2016 PMID: 27421466 PMCID: PMC5288449 DOI: 10.1007/s00038-016-0856-2
Source DB: PubMed Journal: Int J Public Health ISSN: 1661-8556 Impact factor: 3.380
Fig. 1Flow diagram: eligibility assessment of potential studies on waterpipe smoking and cancer identified from literature search or from other sources, for inclusion in the meta-analysis
Characteristics of studies on the association between waterpipe smoking and cancer
| References | Study, year | Cases/controls | OR (95 % CI) | Adjustments | Controls characteristics | Study quality (NOS) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Selection | Comparability | Exposure | NOS | |||||||
| Head and neck | ||||||||||
| Jaferey ( | CC, 1967–1972 | 1192/3562 | 3.10 (2.23–4.29) | Derived from frequencies, adjusted for sex, cigarettes and bidi smoking | Healthy controls matched for age, sex and place of birth | ●●●● | ●● | ○○●○ | 7 | |
| Feng ( | CC, 2002–2005 | 636/615 | 0.49 (0.20–1.23) | Matched analysis adjusted for age and socio-economical status | Hospital controls or friends and family members matched for centre age, sex and childhood household type (urban/rural) | ●●○● | ○● | ○○●● | 6 | |
| Khlifi ( | CC, 2007–2009 | 169/351 | 2.73 (1.65–4.41) | Adjusted for potential risk factors including smoking | Population based controls | ●●●● | ●● | ○○●○ | 7 | |
| Quadri ( | CC, 2014 | 48/96 | 4.20 (1.32–13.3) | Adjusted for other forms of smoking | Hospital controls matched on sex, age (±5 years) and location | ●●○● | ●● | ○○●○ | 6 | |
| Esophagus | ||||||||||
| Cook-Mozaffari ( | CC, 1975–1976 | 217/343 M | 1.25 (0.74–2.08) | Matched analysis | Matched on sex, age (±5 years) and residence | ○●●● | ○● | ○○○○ | 4 | |
| Nasrollahzadeh ( | CC, 2003–2007 | 300/571 | 1.69 (0.76–3.77)a | Matched analysis adjusted for education and ethnicity | Matched on sex, age (±2 years) and residence | ●●●● | ●● | ○○●○ | 7 | |
| Malik ( | CC, 2006–2008 | 135/195 | 21.4 (11.6–39.5) | Adjusted for age and sex | Routine check-up controls matched for age and sex | ●●○● | ○● | ○○●○ | 5 | |
| Khan ( | CC, 2008 | 100/100 | 9.11 (4.44–18.7) | Derived from frequencies | ●●●○● | ○○ | ○○●○ | 4 | ||
| Dar ( | CC, 2008–2012 | 702/1663 | 1.85 (1.41–2.44) | Adjusted for age, ethnicity, religion, residence, education, cigarette, nass, bidi, cannabis, gutka, alcohol, fruit and vegetables intake | Hospital-based controls matched on sex, age (±5 years) and residence | ●●○● | ●● | ○○●● | 7 | |
| Stomach | ||||||||||
| Pourfarzi ( | CC, 2003–2005 | 217/394 | 1.14 (0.29–4.42) | Adjusted for gender, age group, education, family history of GC, various food habits and H. Pylori infection | Community controls matched on sex, age (±5 years) and residence | ●●●● | ●● | ○○●○ | 7 | |
| Shakeri ( | CC, 2004–2011 | 309/613 | 1.10 (0.30–3.30) | Adjusted for age, ethnicity, education, fruit and vegetable consumption, socioeconomic status, opium, cigarette and nass use. | Healthy controls matched on sex, age (±5 years) and residence | ●●●● | ●● | ○○●○ | 7 | |
| Karajibani ( | CC, 2011–2012 | 46/46 | 4.50 (1.17–17.4) | Derived from frequencies | Matched on sex, age, job, economic status | ●●○● | ○○ | ○○●○ | 4 | |
| Sadjadi ( | Cohort of Helicobacter pylori infected subjects; Ardabil, Iran | 36/928 | 3.44 (1.66–7.11) | Adjusted for age, sex, family history of cancer, cigarettes smoking, opium, alcohol, fruit and vegetables and salt. | Average follow-up of 10 years | ●●●● | ●● | ●●● | 9 | |
| Lung | ||||||||||
| Qiao ( | CC, 1967–1984 | 107/107 | 1.90 (0.40–9.40)* | Adjusted for age | ●●●● | ●● | ○○●○ | 7 | ||
| Lubin ( | CC, 1984–1988 | 427/1011 | 1.78 (0.80–4.20)* | Adjusted for age, residence, type of respondent and years of work | Matched on age (±5 years) | ●●●● | ●● | ○○●○ | 7 | |
| Hsairi ( | CC, 1988–1989 | 110/110 | 5.70 (1.20–7.60) | Adjusted for age, sex, cigarette consumption and cannabis use | Matched on sex, age (±5 years) and cigarettes (±5 cig/day) | ●●●● | ●● | ○○●○ | 7 | |
| Gupta ( | CC, 1995–1997 | 265/525 | 1.94 (0.85–4.44) | Adjusted for age and education | Hospital controls matched on sex and age | ●●○● | ○● | ○○●○ | 5 | |
| Koul ( | CC, 2005–2006 | 251/500 | 5.83 (3.95–8.60)* | Crude Odds Ratio | Matched on age and residence | ●●○● | ●● | ○○●○ | 6 | |
| Aoun ( | CC, 2012 | 50/100 | 6.00 (1.78–20.3) | Crude Odds Ratio | Hospital controls and visitors matched on sex | ●●○● | ○○ | ○○●○ | 4 | |
| Bladder | ||||||||||
| Makhyoun ( | CC, 1966–1971 | Bilharzial | 1.08 (0.77–1.51) | Derived from frequencies | Hospital controls matched for antecedent bilharziasis infection, residence and occupation | ●●○● | ○○ | ○○●○ | 4 | |
| Bedwani ( | CC, 1994–1996 | 151/157 | 0.80 (0.20–4.00) | Adjusted for age, education, housing, history of schistosomiasis, high risk occupation and tobacco smoking | Hospital controls with acute non-neoplastic, non-urinary tract, non smoking-related condition | ●●○● | ●● | ○○●○ | 6 | |
| Wolpert ( | CC, N/a | 239/540 | 1.70 (0.38–7.67) | Derived from frequencies | Matched on sex, age (±5 years) and residence | ●●●● | ○● | ○○●○ | 6 | |
| Feki-Tounsi ( | CC, 2007–2010 | 125/204 | 1.32 (0.35–5.00) | Derived from frequencies | Hospital c ontrols consulting for benign disease | ●●○● | ○○ | ○○●○ | 4 | |
| Amr ( | CC, 2006–2011 | 1840/2616 | 1.42 (1.11–1.83)* | Crude Odds Ratios | Residence matched, population-based controls | ●●●● | ●○ | ○○●○ | 6 | |
| Colon-rectum | ||||||||||
| Bener ( | CC, 2008–2009 | 146/282 | 1.02 (0.62–1.68) | Derived from frequencies | Matched on sex, race and age (±5 years) | ●●○● | ○● | ○○● | 6 | |
| Azizi ( | CC, 2013–2014 | 207/207 | 1.26 (0.49–3.27) | Derived from frequencies | Cancer free hospital controls | ●●○● | ○● | ○○●○ | 5 | |
| Liver | ||||||||||
| Soliman ( | CC, 2007–2009 | 150/150 | 1.13 (0.62–2.78) | Matched analysis adjusted for viral infection | Hospital healthy visitors matched on sex and age (±5 years) | ●●○● | ○● | ○○●○ | 5 | |
| All cancer deaths | ||||||||||
| Wu ( | Cohort, 2000–2011 | 47/20033 | 1.30 (0.78–2.18) | Adjusted for age, BMI, education | Average follow-up of 7.6 years | ●●●● | ○● | ●●● | 8 | |
CC case–control study, NOS Newcastle Ottawa Scale score
aRisk estimate for exclusive waterpipe smokers vs. non-smokers of any type of tobacco
Summary odds ratios of the association between waterpipe smoking and selected cancer types
| Cancer site | All studies | Lower quality studies (NOS <7) | Higher quality studies (NOS ≥7) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Studies | OR (95 % CI) |
| Studies | OR (95 % CI) |
| Studies | OR (95 % CI) |
| |
| Head and neck | 4 | 2.12 (1.07–4.19) | 79 | 2 | 1.40 (0.17–11.4) | 88 | 2 | 2.97 (2.26–3.90) | 0 |
| Esophagus | 5 | 3.11 (1.26–7.65) | 93 | 3 | 4.11 (0.91–18.6) | 95 | 2 | 1.84 (1.42–2.38) | 0 |
| Stomach | 4 | 2.21 (1.10–4.47) | 39 | 1 | 4.50 (1.17–17.4) | – | 3 | 1.83 (0.79–4.26) | 49 |
| Lung | 6 | 3.18 (1.87–5.42) | 57 | 3 | 4.13 (1.95–8.72) | 65 | 3 | 2.22 (1.24–3.97) | 0 |
| Bladder | 5 | 1.25 (1.04–1.51) | 0 | 5 | 1.25 (1.04–1.51) | 0 | 0 | – | – |
Quality of the studies assessed using the Newcastle Ottawa scale (higher quality studies had a score ≥7)
Fig. 2Association between waterpipe smoking and cancer of the head and neck, esophagus, stomach, lung and bladder